NALTREXONE

NALTREXONE was reported 31043 times

NALTREXONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ALCOHOLISM 1959 0.4572
1 ALCOHOLIC HANGOVER 14 0.2295
2 ADIPOSIS DOLOROSA 11 0.2292
3 LACK OF ADMINISTRATION SITE ROTATION 61 0.2000
4 INJECTION SITE MOVEMENT IMPAIRMENT 21 0.1641
5 ALCOHOL WITHDRAWAL SYNDROME 117 0.1345
6 BINGE DRINKING 15 0.1327
7 CERVICOGENIC HEADACHE 18 0.1324
8 PINEAL GLAND CYST 18 0.1286
9 ALCOHOL USE 469 0.1270
10 INJECTION SITE CYST 35 0.1195
11 INJECTION SITE NERVE DAMAGE 27 0.1130
12 INFESTATION 28 0.1081
13 PRODUCT ADMINISTERED BY WRONG PERSON 38 0.0995
14 INJECTION SITE ABSCESS 244 0.0980
15 PRODUCT RECONSTITUTION ISSUE 23 0.0730
16 INJECTION SITE INDURATION 912 0.0703
17 ALCOHOL POISONING 181 0.0675
18 MIGRAINE WITHOUT AURA 20 0.0667
19 MALABSORPTION FROM INJECTION SITE 20 0.0645
20 INJECTION SITE REACTION 4410 0.0640
21 IMPRISONMENT 112 0.0633
22 LACK OF INJECTION SITE ROTATION 109 0.0623
23 SUBSTANCE USE 92 0.0589
24 INJECTION SITE CELLULITIS 109 0.0586
25 DETOXIFICATION 20 0.0578
26 INJECTION SITE MASS 1926 0.0520
27 ALCOHOL ABUSE 133 0.0497
28 DRUG SCREEN POSITIVE 390 0.0493
29 CENTRAL PAIN SYNDROME 12 0.0453
30 ANTIDEPRESSANT DISCONTINUATION SYNDROME 9 0.0429
31 DEATH OF RELATIVE 17 0.0419
32 OPIATES POSITIVE 19 0.0396
33 SUBSTANCE ABUSE 309 0.0379
34 INJECTION SITE NECROSIS 74 0.0363
35 SCIATIC NERVE INJURY 30 0.0361
36 DELIRIUM TREMENS 14 0.0347
37 DRUG SCREEN FALSE POSITIVE 94 0.0339
38 HOMELESS 15 0.0337
39 INJECTION SITE INFECTION 110 0.0334
40 DRUG USE DISORDER 277 0.0329
41 MAGNESIUM DEFICIENCY 15 0.0320
42 PRODUCT RECONSTITUTION QUALITY ISSUE 27 0.0302
43 FRACTURE PAIN 16 0.0297
44 HYPERMETABOLISM 15 0.0283
45 NECROSIS ISCHAEMIC 13 0.0282
46 NEEDLE ISSUE 784 0.0269
47 BLOOD ALCOHOL INCREASED 21 0.0268
48 INJECTION SITE PUSTULE 10 0.0262
49 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 477 0.0260
50 EUPHORIC MOOD 253 0.0247
51 CORONAVIRUS INFECTION 163 0.0246
52 INJECTION SITE DISCOMFORT 234 0.0222
53 YAWNING 58 0.0217
54 INADEQUATE ANALGESIA 182 0.0214
55 THERAPEUTIC RESPONSE SHORTENED 701 0.0211
56 PILOERECTION 21 0.0192
57 FEELING OF DESPAIR 89 0.0191
58 EMOTIONAL POVERTY 33 0.0188
59 DIAPHRAGMATIC PARALYSIS 11 0.0184
60 ALCOHOL INTOLERANCE 13 0.0183
61 SUBSTANCE DEPENDENCE 12 0.0178
62 SPONTANEOUS PENILE ERECTION 11 0.0177
63 EOSINOPHILIC PNEUMONIA ACUTE 15 0.0173
64 PRODUCT PHYSICAL CONSISTENCY ISSUE 95 0.0171
65 FEELING DRUNK 124 0.0167
66 AUTOSCOPY 9 0.0167
67 BIPOLAR I DISORDER 36 0.0164
68 MAST CELL ACTIVATION SYNDROME 23 0.0164
69 INJECTION SITE NODULE 172 0.0156
70 EOSINOPHILIC PNEUMONIA 48 0.0152
71 INJECTION SITE INFLAMMATION 74 0.0148
72 CORONAVIRUS TEST POSITIVE 15 0.0146
73 WITHDRAWAL SYNDROME 596 0.0142
74 GLASSY EYES 10 0.0141
75 INJECTION SITE HYPOAESTHESIA 20 0.0140
76 CONTRAINDICATED PRODUCT PRESCRIBED 23 0.0137
77 INJECTION SITE SCAR 39 0.0137
78 INJECTION SITE SCAB 13 0.0135
79 PUNCTATE KERATITIS 12 0.0131
80 OPHTHALMOPLEGIA 20 0.0127
81 SUBSTANCE USE DISORDER 40 0.0125
82 PRODUCT ADMINISTRATION ERROR 250 0.0124
83 INJECTION SITE OEDEMA 21 0.0122
84 MORBID THOUGHTS 14 0.0119
85 PNEUMONIA STREPTOCOCCAL 13 0.0119
86 APATHY 173 0.0118
87 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 16 0.0118
88 INJECTION SITE WARMTH 242 0.0118
89 INJECTION SITE PARAESTHESIA 18 0.0117
90 HANGOVER 41 0.0116
91 FEELINGS OF WORTHLESSNESS 15 0.0115
92 EMBOLIA CUTIS MEDICAMENTOSA 9 0.0113
93 DRUG DETOXIFICATION 10 0.0112
94 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 14 0.0111
95 INJECTION SITE ULCER 10 0.0106
96 HEAT STROKE 16 0.0105
97 VICTIM OF CRIME 13 0.0105
98 INJECTION SITE PAIN 3179 0.0104
99 DENTAL OPERATION 25 0.0101
100 TOBACCO USER 15 0.0101
101 TACHYPHRENIA 34 0.0098
102 TOOTHACHE 177 0.0098
103 FEELING OF BODY TEMPERATURE CHANGE 56 0.0095
104 INHIBITORY DRUG INTERACTION 15 0.0095
105 INTELLECTUAL DISABILITY 14 0.0092
106 INJECTION SITE SWELLING 699 0.0091
107 INJECTION SITE HYPERSENSITIVITY 28 0.0089
108 HEPATIC PAIN 38 0.0089
109 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 149 0.0087
110 DRUG ADMINISTRATION ERROR 266 0.0087
111 LOSS OF EMPLOYMENT 26 0.0086
112 DRUG DEPENDENCE 1378 0.0086
113 SLEEP DEFICIT 18 0.0085
114 WISDOM TEETH REMOVAL 11 0.0083
115 ORAL SURGERY 19 0.0081
116 RESTLESS LEGS SYNDROME 144 0.0079
117 CONTRAINDICATED PRODUCT ADMINISTERED 232 0.0077
118 DENTAL CARE 14 0.0076
119 PRODUCT PREPARATION ISSUE 49 0.0075
120 ACCIDENT AT WORK 16 0.0072
121 ELECTRIC SHOCK SENSATION 20 0.0071
122 RESTLESSNESS 258 0.0070
123 GAMBLING DISORDER 19 0.0070
124 LAZINESS 12 0.0070
125 PRODUCT LEAKAGE 39 0.0069
126 HOMICIDAL IDEATION 28 0.0069
127 NEGATIVE THOUGHTS 20 0.0068
128 PRODUCT PREPARATION ERROR 140 0.0068
129 COLD SWEAT 116 0.0066
130 SLEEP TALKING 11 0.0065
131 FLAT AFFECT 15 0.0065
132 HYPERAMMONAEMIA 32 0.0064
133 PRIAPISM 22 0.0064
134 ENERGY INCREASED 37 0.0063
135 DRUG SCREEN NEGATIVE 11 0.0062
136 PREGNANCY 125 0.0062
137 FOOD INTERACTION 11 0.0062
138 REHABILITATION THERAPY 24 0.0062
139 ROAD TRAFFIC ACCIDENT 259 0.0062
140 FOOD CRAVING 32 0.0061
141 INJECTION SITE HAEMATOMA 88 0.0061
142 DRUG ABUSE 504 0.0060
143 LYME DISEASE 20 0.0060
144 DECREASED INTEREST 35 0.0059
145 FEELING ABNORMAL 1412 0.0059
146 TEMPERATURE REGULATION DISORDER 13 0.0058
147 SCIATICA 93 0.0058
148 NECK INJURY 17 0.0058
149 SENSITIVITY OF TEETH 10 0.0058
150 PRE-EXISTING CONDITION IMPROVED 36 0.0058
151 MOTION SICKNESS 11 0.0057
152 URINARY BLADDER HAEMORRHAGE 12 0.0057
153 HYPERSOMNIA 161 0.0056
154 TOOTH DISORDER 124 0.0056
155 JAW FRACTURE 12 0.0056
156 SNORING 21 0.0055
157 INJECTION SITE INDENTATION 12 0.0055
158 HYPERPHAGIA 22 0.0055
159 ANGER 186 0.0055
160 SELF-INJURIOUS IDEATION 23 0.0055
161 AUTONOMIC NERVOUS SYSTEM IMBALANCE 16 0.0055
162 LIMB MASS 12 0.0055
163 MOOD ALTERED 149 0.0055
164 INJECTION SITE INJURY 30 0.0054
165 HEPATITIS C 65 0.0054
166 TENSION HEADACHE 23 0.0053
167 IRRITABILITY 321 0.0053
168 IMPULSIVE BEHAVIOUR 20 0.0053
169 HAEMATOLOGICAL INFECTION 13 0.0053
170 GUN SHOT WOUND 10 0.0053
171 SYRINGE ISSUE 91 0.0052
172 FORMICATION 36 0.0052
173 DEPRESSED MOOD 273 0.0052
174 CHROMATURIA 116 0.0051
175 OCULAR ICTERUS 22 0.0051
176 FRUSTRATION TOLERANCE DECREASED 41 0.0051
177 MENTAL DISORDER 216 0.0050
178 POISONING 62 0.0049
179 TOOTH EXTRACTION 61 0.0049
180 MASS 68 0.0049
181 WHITE BLOOD CELL DISORDER 13 0.0049
182 PRODUCT PHYSICAL ISSUE 98 0.0049
183 MUSCLE STRAIN 42 0.0048
184 DRUG WITHDRAWAL SYNDROME 420 0.0048
185 NERVE COMPRESSION 44 0.0048
186 OBSESSIVE-COMPULSIVE DISORDER 38 0.0047
187 THINKING ABNORMAL 88 0.0047
188 PRODUCT ADMINISTRATION INTERRUPTED 37 0.0047
189 PRODUCT DOSE OMISSION 307 0.0047
190 SUICIDAL IDEATION 430 0.0047
191 WOUND COMPLICATION 16 0.0047
192 TEARFULNESS 20 0.0046
193 TREATMENT NONCOMPLIANCE 254 0.0046
194 TOOTH FRACTURE 51 0.0046
195 DENTAL CARIES 51 0.0046
196 GASTRIC BYPASS 10 0.0046
197 BEDRIDDEN 60 0.0046
198 PANIC ATTACK 166 0.0046
199 DYSPHORIA 23 0.0045
200 LOGORRHOEA 16 0.0045
201 MUSCULOSKELETAL DISCOMFORT 78 0.0045
202 CRYING 164 0.0045
203 MUSCLE FATIGUE 19 0.0045
204 POST-TRAUMATIC STRESS DISORDER 30 0.0045
205 CLAVICLE FRACTURE 17 0.0044
206 ACCIDENT 53 0.0044
207 ANORGASMIA 12 0.0044
208 MUSCLE TIGHTNESS 71 0.0044
209 DRUG ADMINISTERED AT INAPPROPRIATE SITE 46 0.0044
210 INSOMNIA 1160 0.0044
211 BACK INJURY 47 0.0043
212 REFUSAL OF TREATMENT BY PATIENT 28 0.0043
213 BRAIN FOG 67 0.0043
214 RENAL PAIN 45 0.0042
215 INJECTION SITE DISCOLOURATION 53 0.0042
216 TREMOR 703 0.0042
217 URINARY HESITATION 10 0.0042
218 DEPRESSION 952 0.0042
219 INJECTION SITE IRRITATION 53 0.0042
220 CONCUSSION 32 0.0041
221 SEROTONIN SYNDROME 79 0.0041
222 PRODUCT COLOUR ISSUE 21 0.0041
223 AFFECTIVE DISORDER 32 0.0041
224 SUSPECTED SUICIDE 19 0.0041
225 ARTHROPOD BITE 30 0.0040
226 SURGERY 235 0.0040
227 VIRAL UPPER RESPIRATORY TRACT INFECTION 19 0.0040
228 INJECTION SITE PRURITUS 266 0.0040
229 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 190 0.0040
230 BIPOLAR DISORDER 43 0.0040
231 MOOD SWINGS 126 0.0039
232 ENDODONTIC PROCEDURE 10 0.0039
233 SEXUAL DYSFUNCTION 46 0.0039
234 DEPENDENCE 215 0.0039
235 ANXIETY 1106 0.0039
236 FEELING JITTERY 73 0.0038
237 SLUGGISHNESS 39 0.0038
238 PERSONALITY DISORDER 10 0.0038
239 HAND FRACTURE 27 0.0038
240 ABNORMAL DREAMS 104 0.0038
241 ABSCESS LIMB 16 0.0038
242 ANIMAL BITE 10 0.0037
243 LIMB OPERATION 18 0.0037
244 TRIGEMINAL NEURALGIA 15 0.0037
245 LETHARGY 214 0.0037
246 POOR QUALITY SLEEP 80 0.0037
247 SCHIZOPHRENIA 45 0.0037
248 PRESYNCOPE 90 0.0037
249 CLUMSINESS 10 0.0037
250 SUICIDAL BEHAVIOUR 15 0.0036
251 PAROSMIA 27 0.0036
252 LIQUID PRODUCT PHYSICAL ISSUE 26 0.0036
253 DECREASED APPETITE 823 0.0035
254 INJECTION SITE DISCHARGE 19 0.0035
255 RASH VESICULAR 17 0.0035
256 SHOULDER OPERATION 15 0.0035
257 HYPERACUSIS 13 0.0035
258 DRUG TITRATION ERROR 9 0.0035
259 INJECTION SITE ERYTHEMA 432 0.0035
260 HYPERHIDROSIS 448 0.0035
261 ENURESIS 14 0.0035
262 IMPAIRED WORK ABILITY 74 0.0035
263 SOCIAL AVOIDANT BEHAVIOUR 20 0.0035
264 SCREAMING 22 0.0035
265 FOOT OPERATION 17 0.0034
266 TONGUE DISCOLOURATION 15 0.0034
267 FACE INJURY 13 0.0034
268 INJECTION SITE BRUISING 272 0.0034
269 GASTRIC INFECTION 13 0.0034
270 PROCEDURAL COMPLICATION 26 0.0034
271 NEURALGIA 82 0.0034
272 PARANOIA 58 0.0034
273 APPENDICECTOMY 12 0.0034
274 FEELING COLD 93 0.0033
275 ADVERSE REACTION 44 0.0033
276 INJECTION SITE VESICLES 20 0.0033
277 FEEDING DISORDER 67 0.0033
278 NIGHTMARE 114 0.0033
279 PROCEDURAL PAIN 91 0.0033
280 INCREASED APPETITE 62 0.0032
281 INCOHERENT 21 0.0032
282 THERMAL BURN 23 0.0032
283 ANHEDONIA 85 0.0032
284 PERSONALITY CHANGE 30 0.0032
285 HALLUCINATION, AUDITORY 51 0.0032
286 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 647 0.0032
287 DYSPHEMIA 14 0.0032
288 ABNORMAL BEHAVIOUR 126 0.0032
289 FOOD POISONING 17 0.0032
290 PRODUCT SOLUBILITY ABNORMAL 16 0.0032
291 MUSCLE TWITCHING 73 0.0032
292 SPINAL OPERATION 39 0.0032
293 ANKLE FRACTURE 49 0.0032
294 NERVE INJURY 35 0.0031
295 CARPAL TUNNEL SYNDROME 44 0.0031
296 TENSION 19 0.0031
297 WRIST FRACTURE 37 0.0031
298 THIRST 55 0.0031
299 HOSPITALISATION 472 0.0031
300 OVERDOSE 657 0.0030
301 DEAFNESS NEUROSENSORY 10 0.0030
302 NEAR DEATH EXPERIENCE 10 0.0030
303 MAJOR DEPRESSION 22 0.0030
304 FOOD ALLERGY 23 0.0030
305 FEAR 80 0.0030
306 BLOOD PROLACTIN INCREASED 14 0.0030
307 BRUXISM 16 0.0030
308 SKIN ABRASION 14 0.0030
309 ERECTILE DYSFUNCTION 76 0.0030
310 GAIT DISTURBANCE 566 0.0030
311 KNEE OPERATION 29 0.0029
312 SOMNOLENCE 593 0.0029
313 FEAR OF INJECTION 21 0.0029
314 HALLUCINATION, VISUAL 62 0.0029
315 INJECTION SITE RASH 90 0.0029
316 LIMB INJURY 79 0.0029
317 MALAISE 1274 0.0029
318 FOOT FRACTURE 55 0.0029
319 TINNITUS 133 0.0029
320 FUNCTIONAL GASTROINTESTINAL DISORDER 10 0.0029
321 AGITATION 212 0.0029
322 DISSOCIATION 22 0.0029
323 ERECTION INCREASED 12 0.0029
324 RETCHING 61 0.0029
325 INFUSION SITE SWELLING 18 0.0029
326 ATTENTION DEFICIT HYPERACTIVITY DISORDER 12 0.0028
327 DEPRESSIVE SYMPTOM 10 0.0028
328 INFLUENZA LIKE ILLNESS 233 0.0028
329 BACK DISORDER 46 0.0028
330 EMOTIONAL DISORDER 87 0.0028
331 PERONEAL NERVE PALSY 16 0.0028
332 IMPAIRED DRIVING ABILITY 32 0.0028
333 HEPATIC ENZYME ABNORMAL 14 0.0028
334 PRODUCT DISTRIBUTION ISSUE 26 0.0028
335 FACIAL BONES FRACTURE 10 0.0028
336 PSYCHOMOTOR HYPERACTIVITY 46 0.0028
337 NAUSEA 2165 0.0027
338 MANIA 45 0.0027
339 INTENTIONAL SELF-INJURY 55 0.0027
340 PAIN 1671 0.0027
341 GALLBLADDER OPERATION 11 0.0027
342 LIGAMENT RUPTURE 12 0.0027
343 PSYCHIATRIC SYMPTOM 20 0.0027
344 CEREBRAL DISORDER 20 0.0027
345 AGGRESSION 134 0.0027
346 SELF-MEDICATION 11 0.0027
347 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 482 0.0027
348 WRONG PRODUCT ADMINISTERED 18 0.0027
349 LOWER LIMB FRACTURE 51 0.0027
350 GENERAL PHYSICAL CONDITION ABNORMAL 18 0.0027
351 AUTOIMMUNE THYROIDITIS 10 0.0026
352 NIGHT SWEATS 85 0.0026
353 ABSCESS 42 0.0026
354 HEAD INJURY 83 0.0026
355 MIGRAINE 249 0.0026
356 DISCOMFORT 159 0.0026
357 ADVERSE DRUG REACTION 234 0.0026
358 MOBILITY DECREASED 187 0.0026
359 MOUTH SWELLING 15 0.0026
360 AFFECT LABILITY 25 0.0026
361 FACIAL PAIN 23 0.0026
362 MIDDLE INSOMNIA 48 0.0026
363 MUSCLE RUPTURE 10 0.0026
364 DISTURBANCE IN ATTENTION 138 0.0026
365 GLUCOSE TOLERANCE IMPAIRED 15 0.0025
366 POLYDIPSIA 10 0.0025
367 PRODUCT PRESCRIBING ERROR 60 0.0025
368 EXOSTOSIS 23 0.0025
369 CYST 31 0.0025
370 IMPAIRED GASTRIC EMPTYING 34 0.0025
371 GASTROENTERITIS VIRAL 45 0.0025
372 EATING DISORDER 53 0.0025
373 INJECTION SITE URTICARIA 61 0.0025
374 JOINT INJURY 53 0.0025
375 BOWEL MOVEMENT IRREGULARITY 19 0.0025
376 DRUG DOSE OMISSION 410 0.0025
377 UPPER LIMB FRACTURE 49 0.0025
378 MUSCLE SPASMS 450 0.0024
379 HEAD DISCOMFORT 43 0.0024
380 FIBROMYALGIA 59 0.0024
381 INTERVERTEBRAL DISC PROTRUSION 53 0.0024
382 URINE ABNORMALITY 11 0.0024
383 HEADACHE 1516 0.0024
384 SLEEP APNOEA SYNDROME 46 0.0024
385 HIP SURGERY 13 0.0024
386 HALLUCINATIONS, MIXED 10 0.0024
387 NERVOUSNESS 124 0.0024
388 MIOSIS 19 0.0024
389 JOINT DISLOCATION 25 0.0024
390 TOOTH ABSCESS 24 0.0024
391 APPENDICITIS 22 0.0024
392 MENTAL IMPAIRMENT 57 0.0023
393 FATIGUE 1824 0.0023
394 LIGAMENT SPRAIN 23 0.0023
395 CHILLS 272 0.0023
396 SPINAL PAIN 27 0.0023
397 SALIVARY HYPERSECRETION 23 0.0023
398 SEIZURE 265 0.0023
399 DERMATITIS CONTACT 26 0.0023
400 TOOTH INFECTION 30 0.0023
401 SNEEZING 51 0.0023
402 MYALGIA 386 0.0023
403 APPETITE DISORDER 15 0.0023
404 SCOLIOSIS 14 0.0023
405 ABDOMINAL PAIN UPPER 463 0.0022
406 THERAPEUTIC RESPONSE DECREASED 136 0.0022
407 DYSSTASIA 65 0.0022
408 BURSITIS 27 0.0022
409 DELIRIUM 77 0.0022
410 HALLUCINATION 167 0.0022
411 THERAPEUTIC RESPONSE UNEXPECTED 99 0.0022
412 ABDOMINAL DISCOMFORT 369 0.0022
413 HYSTERECTOMY 19 0.0022
414 EYE MOVEMENT DISORDER 15 0.0022
415 INTENTIONAL UNDERDOSE 16 0.0022
416 ENTERITIS 14 0.0022
417 LOSS OF CONSCIOUSNESS 280 0.0022
418 APNOEA 17 0.0022
419 SENSORY DISTURBANCE 35 0.0022
420 ROTATOR CUFF SYNDROME 28 0.0022
421 VOMITING 1025 0.0022
422 MENSTRUAL DISORDER 18 0.0022
423 HERNIA 42 0.0022
424 UNRESPONSIVE TO STIMULI 56 0.0022
425 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
426 AMMONIA INCREASED 11 0.0022
427 MUSCULOSKELETAL DISORDER 41 0.0022
428 HUNGER 30 0.0022
429 UMBILICAL HERNIA 10 0.0021
430 GASTROINTESTINAL DISORDER 190 0.0021
431 SUICIDE ATTEMPT 128 0.0021
432 INTENTIONAL DOSE OMISSION 60 0.0021
433 SEDATION 55 0.0021
434 MUSCLE RIGIDITY 25 0.0021
435 SUBCUTANEOUS ABSCESS 10 0.0021
436 DIZZINESS 1039 0.0021
437 RHINORRHOEA 134 0.0021
438 LIMB DISCOMFORT 64 0.0021
439 HYPOKINESIA 30 0.0021
440 SLEEP DISORDER 145 0.0021
441 DYSARTHRIA 77 0.0020
442 BEHAVIOUR DISORDER 11 0.0020
443 MYDRIASIS 26 0.0020
444 INJECTION SITE EXTRAVASATION 25 0.0020
445 FEELING HOT 124 0.0020
446 PROCTALGIA 13 0.0020
447 NECK PAIN 113 0.0020
448 GASTROINTESTINAL SOUNDS ABNORMAL 10 0.0020
449 MENTAL STATUS CHANGES 56 0.0020
450 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 94 0.0020
451 DRY MOUTH 163 0.0020
452 HEPATIC ENZYME INCREASED 134 0.0020
453 SKIN MASS 13 0.0019
454 JOINT STIFFNESS 51 0.0019
455 DISORIENTATION 77 0.0019
456 PANIC REACTION 14 0.0019
457 SPINAL OSTEOARTHRITIS 17 0.0019
458 SPEECH DISORDER 101 0.0019
459 COMPLETED SUICIDE 160 0.0019
460 NEPHROLITHIASIS 88 0.0019
461 GAIT INABILITY 64 0.0019
462 BLOOD TESTOSTERONE DECREASED 13 0.0019
463 NO ADVERSE EVENT 344 0.0019
464 BACK PAIN 441 0.0019
465 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 135 0.0019
466 ECCHYMOSIS 13 0.0019
467 PAIN IN EXTREMITY 558 0.0019
468 LOSS OF LIBIDO 17 0.0019
469 ANAL INCONTINENCE 17 0.0019
470 MUSCULOSKELETAL PAIN 99 0.0019
471 DIPLOPIA 49 0.0019
472 IMPAIRED QUALITY OF LIFE 27 0.0019
473 HYPOAESTHESIA 280 0.0019
474 GASTROINTESTINAL MOTILITY DISORDER 10 0.0019
475 PHOTOPHOBIA 35 0.0019
476 AMNESIA 121 0.0019
477 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 102 0.0019
478 DIZZINESS POSTURAL 18 0.0019
479 INITIAL INSOMNIA 19 0.0018
480 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 12 0.0018
481 AUTOIMMUNE DISORDER 18 0.0018
482 MENSTRUATION DELAYED 20 0.0018
483 PHARYNGEAL SWELLING 18 0.0018
484 HIP ARTHROPLASTY 28 0.0018
485 DRUG EFFECT LESS THAN EXPECTED 27 0.0018
486 DISABILITY 36 0.0018
487 DEPRESSED LEVEL OF CONSCIOUSNESS 72 0.0018
488 WEIGHT FLUCTUATION 19 0.0018
489 AGEUSIA 45 0.0018
490 STREPTOCOCCAL INFECTION 10 0.0018
491 NECROSIS 10 0.0018
492 GLOMERULAR FILTRATION RATE DECREASED 22 0.0018
493 BREAST MASS 12 0.0018
494 NEUROLEPTIC MALIGNANT SYNDROME 21 0.0018
495 INFUSION SITE EXTRAVASATION 11 0.0018
496 SEASONAL ALLERGY 25 0.0018
497 BODY TEMPERATURE INCREASED 36 0.0018
498 PSYCHOTIC DISORDER 52 0.0018
499 UNDERDOSE 128 0.0018
500 SKIN LACERATION 19 0.0017
501 BLEPHAROSPASM 11 0.0017
502 INTENTIONAL OVERDOSE 112 0.0017
503 CONFUSIONAL STATE 282 0.0017
504 VIRAL INFECTION 58 0.0017
505 OFF LABEL USE 1525 0.0017
506 MUSCLE ATROPHY 22 0.0017
507 IRON DEFICIENCY ANAEMIA 16 0.0017
508 MYASTHENIA GRAVIS 14 0.0017
509 DYSKINESIA 70 0.0017
510 SKIN WARM 10 0.0017
511 PRODUCT DOSE OMISSION ISSUE 505 0.0017
512 HAEMOGLOBIN ABNORMAL 11 0.0017
513 FLANK PAIN 16 0.0017
514 SINUS CONGESTION 23 0.0017
515 URINE ODOUR ABNORMAL 10 0.0017
516 IMMUNOSUPPRESSION 15 0.0017
517 ARTHRALGIA 705 0.0017
518 PURPURA 15 0.0017
519 ORAL HERPES 33 0.0017
520 MUSCULOSKELETAL STIFFNESS 148 0.0017
521 DYSURIA 62 0.0017
522 SINUS HEADACHE 10 0.0017
523 BURNING SENSATION 118 0.0017
524 CELLULITIS 84 0.0017
525 OROPHARYNGEAL PAIN 154 0.0017
526 UNEVALUABLE EVENT 124 0.0016
527 ASTHENOPIA 9 0.0016
528 RETINAL DETACHMENT 15 0.0016
529 MENISCUS INJURY 10 0.0016
530 GALLBLADDER DISORDER 29 0.0016
531 PRODUCT LABEL ISSUE 11 0.0016
532 ACTIVITIES OF DAILY LIVING IMPAIRED 32 0.0016
533 BLADDER DISORDER 16 0.0016
534 RIB FRACTURE 33 0.0016
535 MOVEMENT DISORDER 51 0.0016
536 ACNE 120 0.0016
537 PHOTOPSIA 10 0.0016
538 BONE PAIN 92 0.0016
539 DEFAECATION URGENCY 11 0.0016
540 RIGHT VENTRICULAR FAILURE 11 0.0016
541 HYPOPHAGIA 40 0.0016
542 EAR DISCOMFORT 16 0.0016
543 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
544 OCCUPATIONAL EXPOSURE TO PRODUCT 10 0.0016
545 OROPHARYNGEAL DISCOMFORT 14 0.0015
546 AKATHISIA 21 0.0015
547 MULTIPLE ALLERGIES 12 0.0015
548 ATAXIA 18 0.0015
549 WEIGHT INCREASED 339 0.0015
550 ASTHENIA 565 0.0015
551 MEMORY IMPAIRMENT 206 0.0015
552 PARAESTHESIA 235 0.0015
553 BLINDNESS TRANSIENT 11 0.0015
554 SWELLING 139 0.0015
555 WEIGHT DECREASED 414 0.0015
556 NASAL CONGESTION 87 0.0015
557 GROIN PAIN 13 0.0015
558 PHARYNGITIS STREPTOCOCCAL 16 0.0015
559 SPINAL DISORDER 14 0.0015
560 KIDNEY INFECTION 29 0.0015
561 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 25 0.0015
562 OESOPHAGITIS 16 0.0015
563 SINUS DISORDER 29 0.0015
564 EMOTIONAL DISTRESS 177 0.0015
565 HYPERAESTHESIA 12 0.0015
566 GASTROINTESTINAL PAIN 16 0.0015
567 HEART RATE INCREASED 144 0.0015
568 ONYCHOCLASIS 10 0.0015
569 ECONOMIC PROBLEM 22 0.0015
570 MUSCLE INJURY 12 0.0014
571 PRESCRIBED OVERDOSE 28 0.0014
572 ILLNESS 149 0.0014
573 LIVER FUNCTION TEST INCREASED 31 0.0014
574 EAR PAIN 28 0.0014
575 TENDERNESS 15 0.0014
576 HEPATIC CIRRHOSIS 27 0.0014
577 BALANCE DISORDER 124 0.0014
578 DRUG EFFECT DECREASED 77 0.0014
579 ORAL PAIN 32 0.0014
580 INFUSION SITE ERYTHEMA 12 0.0014
581 NASOPHARYNGITIS 262 0.0014
582 SKIN REACTION 20 0.0014
583 APHTHOUS ULCER 11 0.0014
584 STATUS EPILEPTICUS 16 0.0014
585 DRUG INTERACTION 224 0.0014
586 HEPATITIS 36 0.0014
587 MUSCULAR WEAKNESS 158 0.0014
588 GENERALISED TONIC-CLONIC SEIZURE 23 0.0014
589 PARAESTHESIA ORAL 20 0.0014
590 MOTOR DYSFUNCTION 14 0.0014
591 ASPIRATION 15 0.0014
592 SWELLING FACE 89 0.0014
593 SENSORY LOSS 11 0.0014
594 INJECTION SITE HAEMORRHAGE 109 0.0014
595 DEHYDRATION 182 0.0014
596 RHINITIS 11 0.0014
597 THERAPY CESSATION 70 0.0014
598 COORDINATION ABNORMAL 19 0.0014
599 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 12 0.0014
600 INJURY 95 0.0014
601 HEPATIC STEATOSIS 25 0.0013
602 JAUNDICE 36 0.0013
603 PALPITATIONS 156 0.0013
604 COVID-19 232 0.0013
605 TENDON PAIN 10 0.0013
606 ULCER 21 0.0013
607 INFUSION SITE PAIN 17 0.0013
608 SYNCOPE 132 0.0013
609 MULTIPLE SCLEROSIS 63 0.0013
610 SCAB 15 0.0013
611 HOT FLUSH 99 0.0013
612 BREAST PAIN 14 0.0013
613 BLOOD PRESSURE ABNORMAL 26 0.0013
614 LIPASE INCREASED 10 0.0013
615 DROOLING 9 0.0013
616 DECREASED ACTIVITY 14 0.0013
617 SPINAL FRACTURE 26 0.0013
618 FREQUENT BOWEL MOVEMENTS 35 0.0013
619 PANCREATITIS ACUTE 29 0.0013
620 IMMUNE SYSTEM DISORDER 17 0.0013
621 APHONIA 18 0.0013
622 VITAMIN D DECREASED 11 0.0013
623 PELVIC FRACTURE 10 0.0013
624 DRY EYE 64 0.0013
625 TASTE DISORDER 26 0.0013
626 DRY THROAT 13 0.0013
627 DIARRHOEA 822 0.0013
628 STAPHYLOCOCCAL INFECTION 42 0.0013
629 THERAPEUTIC PRODUCT EFFECT DECREASED 57 0.0013
630 PERIPHERAL SWELLING 196 0.0013
631 SINUS TACHYCARDIA 18 0.0013
632 CONTUSION 122 0.0013
633 VERTIGO 77 0.0013
634 HYPOAESTHESIA ORAL 19 0.0013
635 HYPERLIPIDAEMIA 15 0.0013
636 AMENORRHOEA 22 0.0013
637 MALNUTRITION 14 0.0013
638 GRIP STRENGTH DECREASED 11 0.0012
639 URINARY INCONTINENCE 37 0.0012
640 INSURANCE ISSUE 19 0.0012
641 EYE SWELLING 46 0.0012
642 CHEST PAIN 228 0.0012
643 URINARY RETENTION 41 0.0012
644 FALL 408 0.0012
645 VISION BLURRED 168 0.0012
646 RHABDOMYOLYSIS 51 0.0012
647 HAEMATEMESIS 31 0.0012
648 POLLAKIURIA 51 0.0012
649 INFLUENZA 136 0.0012
650 COMA 58 0.0012
651 LIVER DISORDER 54 0.0012
652 NERVOUS SYSTEM DISORDER 38 0.0012
653 HYPERSENSITIVITY 226 0.0012
654 WOUND 34 0.0012
655 HEREDITARY ANGIOEDEMA 13 0.0012
656 THROAT IRRITATION 54 0.0012
657 DRUG INEFFECTIVE 1580 0.0012
658 BRAIN INJURY 12 0.0012
659 LACRIMATION INCREASED 36 0.0012
660 ARTHROPATHY 66 0.0012
661 CARDIOGENIC SHOCK 17 0.0012
662 BLOOD BILIRUBIN INCREASED 32 0.0012
663 DRUG LEVEL DECREASED 12 0.0012
664 PRODUCTIVE COUGH 56 0.0012
665 DRUG INTOLERANCE 113 0.0012
666 PERIPHERAL COLDNESS 16 0.0012
667 TEMPERATURE INTOLERANCE 12 0.0012
668 SKIN INFECTION 13 0.0012
669 DELUSION 18 0.0012
670 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 9 0.0012
671 HIATUS HERNIA 15 0.0012
672 DYSGEUSIA 86 0.0012
673 DYSPEPSIA 113 0.0011
674 LIP SWELLING 38 0.0011
675 PALLOR 31 0.0011
676 PULMONARY CONGESTION 15 0.0011
677 SCRATCH 12 0.0011
678 PANCREATITIS 60 0.0011
679 BLOOD PRESSURE INCREASED 173 0.0011
680 RESPIRATORY RATE INCREASED 10 0.0011
681 URTICARIA 188 0.0011
682 BODY HEIGHT DECREASED 12 0.0011
683 SKIN ULCER 29 0.0011
684 VITREOUS FLOATERS 11 0.0011
685 PARALYSIS 16 0.0011
686 SCAR 19 0.0011
687 PRURITUS GENERALISED 24 0.0011
688 DECUBITUS ULCER 9 0.0011
689 THYROID DISORDER 17 0.0011
690 SINUSITIS 113 0.0011
691 GASTRITIS 29 0.0011
692 PRODUCT PRESCRIBING ISSUE 24 0.0011
693 JOINT SWELLING 131 0.0011
694 INFECTION 157 0.0011
695 DIVERTICULITIS 30 0.0011
696 HAEMATOMA 28 0.0011
697 SKIN HAEMORRHAGE 16 0.0011
698 SKIN DISORDER 36 0.0011
699 PNEUMOTHORAX 17 0.0011
700 NOCTURIA 13 0.0011
701 CONSTIPATION 233 0.0011
702 BLOOD TEST ABNORMAL 15 0.0011
703 CHEST DISCOMFORT 109 0.0011
704 SWOLLEN TONGUE 33 0.0011
705 OSTEOPENIA 16 0.0011
706 SUPRAVENTRICULAR TACHYCARDIA 10 0.0010
707 ABDOMINAL PAIN 243 0.0010
708 GASTROOESOPHAGEAL REFLUX DISEASE 84 0.0010
709 QUALITY OF LIFE DECREASED 14 0.0010
710 WHITE BLOOD CELL COUNT INCREASED 40 0.0010
711 TACHYCARDIA 92 0.0010
712 THROAT TIGHTNESS 28 0.0010
713 VASCULITIS 12 0.0010
714 IRRITABLE BOWEL SYNDROME 22 0.0010
715 NEUROPATHY PERIPHERAL 97 0.0010
716 EAR INFECTION 27 0.0010
717 BLOOD IRON DECREASED 12 0.0010
718 MEDICATION ERROR 56 0.0010
719 BLOOD CREATINE PHOSPHOKINASE INCREASED 29 0.0010
720 IMMUNODEFICIENCY 15 0.0010
721 ABDOMINAL DISTENSION 105 0.0010
722 OBESITY 16 0.0010
723 OVARIAN CYST 10 0.0010
724 NODULE 13 0.0010
725 BRONCHITIS 73 0.0010
726 COGNITIVE DISORDER 46 0.0010
727 SKIN LESION 27 0.0010
728 TOXICITY TO VARIOUS AGENTS 165 0.0010
729 ORTHOSTATIC HYPOTENSION 17 0.0010
730 HEART RATE IRREGULAR 22 0.0010
731 DYSPHAGIA 92 0.0010
732 MUSCULOSKELETAL CHEST PAIN 15 0.0010
733 POOR VENOUS ACCESS 10 0.0010
734 THERAPY PARTIAL RESPONDER 15 0.0010
735 GASTROENTERITIS 14 0.0010
736 SECRETION DISCHARGE 12 0.0010
737 THERAPY NON-RESPONDER 43 0.0010
738 RASH 415 0.0010
739 BLOOD URINE PRESENT 18 0.0009
740 PYREXIA 325 0.0009
741 POST PROCEDURAL COMPLICATION 18 0.0009
742 INTENTIONAL PRODUCT USE ISSUE 82 0.0009
743 RESPIRATORY DISORDER 28 0.0009
744 APHASIA 28 0.0009
745 FLUID RETENTION 47 0.0009
746 ALOPECIA 181 0.0009
747 BLOOD PRESSURE DECREASED 61 0.0009
748 BLOOD PRESSURE FLUCTUATION 22 0.0009
749 BODY TEMPERATURE DECREASED 9 0.0009
750 HEART RATE DECREASED 32 0.0009
751 PHARYNGEAL OEDEMA 14 0.0009
752 SARS-COV-2 TEST POSITIVE 12 0.0009
753 PHOTOSENSITIVITY REACTION 15 0.0009
754 TENDONITIS 14 0.0009
755 EYE IRRITATION 52 0.0009
756 FOOT DEFORMITY 10 0.0009
757 ANOSMIA 13 0.0009
758 MUSCLE SPASTICITY 11 0.0009
759 RASH PAPULAR 20 0.0009
760 GOUT 16 0.0009
761 INFLAMMATION 46 0.0009
762 TENDON RUPTURE 11 0.0009
763 RASH GENERALISED 23 0.0009
764 HERPES ZOSTER 51 0.0009
765 PELVIC PAIN 16 0.0009
766 HYPOTHYROIDISM 28 0.0009
767 PRODUCT QUALITY ISSUE 119 0.0009
768 LOCALISED INFECTION 21 0.0009
769 TOOTH LOSS 18 0.0009
770 INCORRECT ROUTE OF DRUG ADMINISTRATION 31 0.0009
771 RASH PRURITIC 47 0.0009
772 ASPARTATE AMINOTRANSFERASE INCREASED 46 0.0009
773 FLUSHING 88 0.0009
774 COUGH 242 0.0009
775 RENAL DISORDER 40 0.0009
776 PRURITUS 329 0.0009
777 KNEE ARTHROPLASTY 18 0.0009
778 DYSPNOEA 483 0.0009
779 PAIN IN JAW 24 0.0008
780 PRODUCT STORAGE ERROR 74 0.0008
781 HIP FRACTURE 27 0.0008
782 PSORIATIC ARTHROPATHY 34 0.0008
783 BLOOD POTASSIUM DECREASED 25 0.0008
784 LEUKOCYTOSIS 15 0.0008
785 PRODUCT DISPENSING ERROR 18 0.0008
786 COMPLICATION ASSOCIATED WITH DEVICE 12 0.0008
787 HYPERGLYCAEMIA 30 0.0008
788 ILL-DEFINED DISORDER 50 0.0008
789 IMPAIRED HEALING 27 0.0008
790 EYE DISORDER 27 0.0008
791 HAEMORRHOIDS 16 0.0008
792 NO THERAPEUTIC RESPONSE 10 0.0008
793 CYSTITIS 26 0.0008
794 CONDITION AGGRAVATED 248 0.0008
795 TARDIVE DYSKINESIA 23 0.0008
796 ALANINE AMINOTRANSFERASE INCREASED 50 0.0008
797 ABASIA 20 0.0008
798 BLOOD ALKALINE PHOSPHATASE INCREASED 20 0.0008
799 INCORRECT DOSE ADMINISTERED 183 0.0008
800 HYPOKALAEMIA 37 0.0008
801 ARTHRITIS 63 0.0008
802 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
803 INFUSION RELATED REACTION 53 0.0008
804 BLOOD SODIUM DECREASED 15 0.0008
805 HYPOXIA 28 0.0008
806 FLATULENCE 45 0.0008
807 BLOOD TRIGLYCERIDES INCREASED 14 0.0008
808 ORAL DISCOMFORT 11 0.0008
809 LYMPHADENOPATHY 28 0.0008
810 GASTRIC ULCER 15 0.0008
811 HYPERTENSION 167 0.0008
812 CHOLECYSTECTOMY 9 0.0008
813 DYSPHONIA 46 0.0008
814 DRUG LEVEL INCREASED 13 0.0008
815 PNEUMONIA 254 0.0008
816 FAECES DISCOLOURED 17 0.0008
817 MENSTRUATION IRREGULAR 21 0.0008
818 CLOSTRIDIUM DIFFICILE INFECTION 17 0.0008
819 ELECTROLYTE IMBALANCE 9 0.0008
820 URINARY TRACT INFECTION 130 0.0008
821 PRODUCT USE COMPLAINT 12 0.0008
822 SKIN DISCOLOURATION 35 0.0008
823 INCORRECT PRODUCT STORAGE 10 0.0008
824 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 54 0.0008
825 ANKYLOSING SPONDYLITIS 10 0.0008
826 ABDOMINAL PAIN LOWER 19 0.0008
827 VISUAL IMPAIRMENT 93 0.0007
828 EYE PAIN 42 0.0007
829 HYPOACUSIS 32 0.0007
830 WHEEZING 44 0.0007
831 INJURY ASSOCIATED WITH DEVICE 15 0.0007
832 UPPER RESPIRATORY TRACT INFECTION 34 0.0007
833 LIVER INJURY 18 0.0007
834 HAEMATOCHEZIA 40 0.0007
835 FUNGAL INFECTION 24 0.0007
836 HEPATOTOXICITY 16 0.0007
837 OCULAR HYPERAEMIA 34 0.0007
838 FEMUR FRACTURE 22 0.0007
839 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 37 0.0007
840 HEMIPARESIS 12 0.0007
841 BLOOD CHOLESTEROL INCREASED 33 0.0007
842 ADVERSE EVENT 65 0.0007
843 PRESCRIBED UNDERDOSE 14 0.0007
844 DERMATITIS ATOPIC 37 0.0007
845 ANGIOEDEMA 31 0.0007
846 GASTRIC DISORDER 24 0.0007
847 SKIN BURNING SENSATION 50 0.0007
848 RASH ERYTHEMATOUS 33 0.0007
849 FRACTURE 13 0.0007
850 LOWER RESPIRATORY TRACT INFECTION 31 0.0007
851 LYMPHOCYTE COUNT DECREASED 12 0.0007
852 DEATH 583 0.0007
853 ACUTE RESPIRATORY FAILURE 13 0.0007
854 DISEASE RECURRENCE 32 0.0007
855 CHOLELITHIASIS 22 0.0007
856 ANAPHYLACTIC REACTION 37 0.0007
857 BLINDNESS 27 0.0007
858 MENORRHAGIA 13 0.0007
859 BLISTER 37 0.0007
860 OXYGEN SATURATION DECREASED 37 0.0007
861 PRODUCT USE IN UNAPPROVED INDICATION 163 0.0007
862 EYE PRURITUS 22 0.0007
863 ABORTION SPONTANEOUS 26 0.0006
864 MULTIPLE SCLEROSIS RELAPSE 44 0.0006
865 ELECTROCARDIOGRAM QT PROLONGED 23 0.0006
866 OSTEOARTHRITIS 27 0.0006
867 PRODUCT DOSE OMISSION IN ERROR 18 0.0006
868 GLYCOSYLATED HAEMOGLOBIN INCREASED 16 0.0006
869 THROMBOSIS 51 0.0006
870 PAIN OF SKIN 17 0.0006
871 ECZEMA 33 0.0006
872 RESPIRATORY TRACT CONGESTION 10 0.0006
873 CHOLESTASIS 12 0.0006
874 ACUTE RESPIRATORY DISTRESS SYNDROME 11 0.0006
875 ASTHMA 69 0.0006
876 COLITIS ULCERATIVE 27 0.0006
877 ACCIDENTAL OVERDOSE 22 0.0006
878 RASH MACULAR 21 0.0006
879 ALTERED STATE OF CONSCIOUSNESS 13 0.0006
880 HEPATIC FAILURE 18 0.0006
881 CANDIDA INFECTION 10 0.0006
882 OEDEMA 32 0.0006
883 EPISTAXIS 44 0.0006
884 GAMMA-GLUTAMYLTRANSFERASE INCREASED 13 0.0006
885 RECTAL HAEMORRHAGE 25 0.0006
886 PULMONARY OEDEMA 26 0.0006
887 RESPIRATORY TRACT INFECTION 15 0.0006
888 DRUG PRESCRIBING ERROR 11 0.0006
889 MATERNAL EXPOSURE DURING PREGNANCY 51 0.0006
890 INTENTIONAL PRODUCT MISUSE 50 0.0006
891 ERYTHEMA 117 0.0006
892 PRODUCT USE ISSUE 106 0.0006
893 SYSTEMIC LUPUS ERYTHEMATOSUS 20 0.0006
894 PNEUMONIA ASPIRATION 14 0.0006
895 OSTEOPOROSIS 23 0.0006
896 CARDIAC DISORDER 52 0.0006
897 HAEMATOCRIT DECREASED 11 0.0006
898 BLOOD POTASSIUM INCREASED 9 0.0006
899 DIABETES MELLITUS 42 0.0006
900 BONE DISORDER 10 0.0005
901 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 16 0.0005
902 RHEUMATOID ARTHRITIS 62 0.0005
903 STEVENS-JOHNSON SYNDROME 12 0.0005
904 HYPOTENSION 108 0.0005
905 INTESTINAL OBSTRUCTION 20 0.0005
906 ENCEPHALOPATHY 13 0.0005
907 PSORIASIS 69 0.0005
908 ERUCTATION 10 0.0005
909 LIVER FUNCTION TEST ABNORMAL 15 0.0005
910 HYPONATRAEMIA 29 0.0005
911 ANAEMIA 98 0.0005
912 EXPIRED PRODUCT ADMINISTERED 17 0.0005
913 SKIN CANCER 11 0.0005
914 PULMONARY EMBOLISM 48 0.0005
915 COMPLICATION OF DEVICE REMOVAL 9 0.0005
916 DEAFNESS 13 0.0005
917 DEVICE BREAKAGE 20 0.0005
918 BRADYCARDIA 26 0.0005
919 LUNG DISORDER 24 0.0005
920 RENAL FAILURE 65 0.0005
921 BLOOD GLUCOSE ABNORMAL 9 0.0005
922 PRODUCT SUBSTITUTION ISSUE 28 0.0005
923 HEPATIC FUNCTION ABNORMAL 18 0.0005
924 BLOOD GLUCOSE DECREASED 23 0.0005
925 BONE DENSITY DECREASED 15 0.0005
926 STOMATITIS 29 0.0005
927 DRY SKIN 63 0.0005
928 SEPTIC SHOCK 20 0.0005
929 TREATMENT FAILURE 38 0.0005
930 EPILEPSY 14 0.0005
931 RED BLOOD CELL COUNT DECREASED 13 0.0005
932 RESPIRATORY FAILURE 33 0.0005
933 ACUTE KIDNEY INJURY 69 0.0005
934 CHRONIC KIDNEY DISEASE 34 0.0004
935 TYPE 2 DIABETES MELLITUS 15 0.0004
936 LABORATORY TEST ABNORMAL 13 0.0004
937 VAGINAL HAEMORRHAGE 19 0.0004
938 CATARACT 26 0.0004
939 RESPIRATORY ARREST 12 0.0004
940 THERAPY INTERRUPTED 31 0.0004
941 DEMENTIA 12 0.0004
942 BLOOD CREATININE INCREASED 28 0.0004
943 ANAPHYLACTIC SHOCK 11 0.0004
944 CARDIAC ARREST 35 0.0004
945 INCORRECT DOSE ADMINISTERED BY DEVICE 11 0.0004
946 DIABETIC KETOACIDOSIS 10 0.0004
947 DEEP VEIN THROMBOSIS 27 0.0004
948 TRANSIENT ISCHAEMIC ATTACK 14 0.0004
949 SKIN EXFOLIATION 35 0.0004
950 SKIN IRRITATION 19 0.0004
951 OEDEMA PERIPHERAL 50 0.0004
952 RENAL INJURY 12 0.0004
953 SEPSIS 45 0.0004
954 EXPOSURE DURING PREGNANCY 25 0.0004
955 RESPIRATORY DISTRESS 11 0.0004
956 WRONG TECHNIQUE IN DRUG USAGE PROCESS 14 0.0004
957 ANGINA PECTORIS 11 0.0004
958 CARDIO-RESPIRATORY ARREST 16 0.0004
959 ARRHYTHMIA 18 0.0004
960 CEREBROVASCULAR ACCIDENT 64 0.0004
961 CONVULSION 21 0.0004
962 GENERAL PHYSICAL HEALTH DETERIORATION 42 0.0004
963 NEOPLASM MALIGNANT 24 0.0004
964 HAEMOPTYSIS 10 0.0004
965 GYNAECOMASTIA 11 0.0004
966 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 9 0.0003
967 HAEMOGLOBIN DECREASED 35 0.0003
968 ASCITES 10 0.0003
969 LEUKOPENIA 17 0.0003
970 ACCIDENTAL EXPOSURE TO PRODUCT 35 0.0003
971 WHITE BLOOD CELL COUNT DECREASED 36 0.0003
972 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 11 0.0003
973 HAEMORRHAGE 32 0.0003
974 COLITIS 11 0.0003
975 GASTROINTESTINAL HAEMORRHAGE 24 0.0003
976 BLOOD GLUCOSE INCREASED 53 0.0003
977 DEVICE DISLOCATION 12 0.0003
978 MYOCARDIAL INFARCTION 45 0.0003
979 HYPOGLYCAEMIA 12 0.0002
980 EXTRA DOSE ADMINISTERED 10 0.0002
981 DEVICE ISSUE 22 0.0002
982 RENAL IMPAIRMENT 20 0.0002
983 ATRIAL FIBRILLATION 21 0.0002
984 DEVICE MALFUNCTION 14 0.0002
985 PLEURAL EFFUSION 12 0.0002
986 FOETAL EXPOSURE DURING PREGNANCY 16 0.0002
987 CARDIAC FAILURE 15 0.0002
988 BREAST CANCER 16 0.0002
989 PLATELET COUNT DECREASED 17 0.0002
990 NEUTROPENIA 20 0.0001
991 CARDIAC FAILURE CONGESTIVE 11 0.0001
992 THROMBOCYTOPENIA 15 0.0001
993 DISEASE PROGRESSION 12 0.0001